KS has lectured for Amgen, AstraZeneca, Bayer, OmniaMed, Lilly, Boehringer Ingelheim, Novartis, NovoNordisc and MSD and acted as consultant to AstraZeneca, Amgen, Böhringer Ingelheim and Lilly. KS also carried out a research project supported by Boehringer Ingelheim.; DMW has lectured and advised Amgen, AstraZeneca, Boehringer Ingelheim, MSD, NovoNordisk and Sanofi-Aventis. NM has lectured for Amgen, Boehringer Ingelheim, Sanofi-Aventis, MSD, BMS, AstraZeneca, Lilly, NovoNordisk; NM has conducted research projects supported by Boehringer Ingelheim and MSD and has acted as consultant to Amgen, Boehringer Ingelheim, Sanofi-Aventis, MSD, BMS, AstraZeneca, NovoNordisk, Lilly and Bayer.; ALB has lectured for Amgen, AstraZeneca, Lilly, Boehringer Ingelheim, NovoNordisc, and MSD, and served as a consultant for Böhringer Ingelheim, AstraZeneca, and NovoNordisk.; AZ has acted as consultant for: Bayer Health Care; Boehringer Ingelheim; Rigel; Cardiorentis; Medscape; Stealth Peptides; Sanofi Aventis; Medtronic; Novartis. He received honoraria from: Bayer Health Care; Astra-Zeneca; Medtronic; ResMed; Boehringer Ingelheim; Rigel; Sanofi Aventis; Pfizer; Janssen-Cilag; Novartis; Bristol Myers Squib; Thoratec; Abiomed; Daiichi Sankyo; Abbott; Cardiac Dimensions.; TF has the following conflicts of interest: Speaker Panel: Abbott; Astra Zeneca; Böhringer Ingelheim, Berlin Chemie; Cipla, Eli Lilly; Fortbildungskolleg; MSD; Novartis, Novo Nordisk; Sanofi. Advisory Panel: Astra Zeneca; Bayer; Cipla, Eli Lilly; Fortbildungskolleg; Novo Nordisk; Pfizer; Sanofi; Bayer; Roche; Eyesense.